Her Daughter Died After Taking Tacrolimus. This Is What She Wants You to Know. — ProPublica
When I first learned that a critical medication for transplant patients — one that keeps them alive —…
I was an asylum seeker and A&E doctor — now I run a £12m business
Thuria Wenbar’s parents were doctors in Iraq before the family arrived in the UK as asylum seekers in…
Wirral care home nurse forced pills into residents’ mouths
Jonny HumphriesNorth West Google Davina Owen was sacked by Norway Lodge Care Home after residents spoke up about…
Which Is the Better Stock Buy?
Eli Lilly leads the weight loss market ahead of Novo Nordisk. Eli Lilly also has a more diversified…
AI is Sparking Optimism in Rare-Disease Research
The first nine days of Jorie Kraus’s life followed a pattern: problem, solution. Problem, solution. Problem: Jorie was…
Five Takeaways From The 2026 J.P. Morgan Healthcare Conference
The author Juergen Eckhardt, pictured center, speaking this week at a panel on medical innovation hosted by the…
Health department to launch study on cellphone radiation
The U.S. Department of Health and Human Services will launch a study on cellphone radiation, a department spokesman…
Novo Nordisk shares rise after Wegovy obesity pill launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
BGI Genomics, Roche roll out diagnostic tests for Alzheimer’s in China
SHANGHAI, Jan 14 (Reuters) – BGI Genomics (300676.SZ), opens new tab and Roche Diagnostics (ROG.S), opens new tab…
Billion-dollar prescription: Can Kerala’s healthcare survive private equity rush? | Business
Over the last two years, a quiet but consequential transformation has taken place in Kerala’s socio-economic landscape. As…
Exercise Shows Similar Results to Therapy
Share on PinterestA recent review shows that exercise may be nearly as effective as therapy for depression. Image…
What to do if you’ve been exposed to measles
The United States reported a record number of measles cases in 2025, and the virus continues to spread…